Cargando…
Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C
Previous studies have demonstrated the inhibitory effect of microRNA (miR)-196a on hepatitis C virus (HCV) expression in human hepatocytes. However, the clinical implications of aberrant miR-196a expression and the application of circulating miR-196a in the diagnosis and management of chronic hepati...
Autores principales: | LIU, BO, XIANG, YING, ZHANG, HENG-SHU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438874/ https://www.ncbi.nlm.nih.gov/pubmed/25738504 http://dx.doi.org/10.3892/mmr.2015.3386 |
Ejemplares similares
-
Circulating microRNA-196a is an early gastric cancer biomarker
por: Chen, Tsung-Hsing, et al.
Publicado: (2017) -
The diagnostic and prognostic values of microRNA-196a in cancer
por: Xiong, Mengqiu, et al.
Publicado: (2021) -
MicroRNA-196a Is a Putative Diagnostic Biomarker and Therapeutic Target for Laryngeal Cancer
por: Saito, Koichiro, et al.
Publicado: (2013) -
MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer
por: Slater, Emily P., et al.
Publicado: (2014) -
Combined Elevation of microRNA-196a and microRNA-196b in Sera Predicts Unfavorable Prognosis in Patients with Osteosarcomas
por: Zhang, Chun, et al.
Publicado: (2014)